Olimel N12e

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel N12e, is a mixture of essential and non‑essential amino acids presented as a sterile powder for intravenous use. It supports metabolic functions and protein synthesis in patients requiring nutritional support.

GNH USA supplies Olimel N12e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Olimel N12e provides amino acid supplementation for metabolic and nutritional support pathways. - Protein‑energy malnutrition: helps restore nitrogen balance and supports tissue repair. - Post‑operative recovery: contributes to wound healing and lean‑body‑mass preservation. - Critical illness or severe trauma: assists in maintaining muscle mass and immune function during catabolic stress.

Amino acid solutions may be associated with infusion‑related reactions and metabolic disturbances.

Common Side Effects: - Nausea: mild gastrointestinal discomfort reported during infusion. - Vomiting: occasional emesis following administration. - Headache: transient headache during or after infusion. - Hyperglycaemia: elevation of blood glucose in susceptible individuals. - Mild electrolyte shift: slight changes in serum potassium or sodium. - Local irritation: redness or warmth at the infusion site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical intervention. - Sepsis: contamination‑related infection if aseptic technique is breached. - Metabolic acidosis: significant acid‑base imbalance in vulnerable patients. - Hyperosmolarity: high osmolar load causing fluid shifts. - Thrombophlebitis: inflammation of the vein with clot formation. - Renal impairment: worsening kidney function in patients with pre‑existing disease.

When using Olimel N12e, clinicians should assess patient suitability and monitor relevant parameters. - Renal function: evaluate creatinine clearance before initiation. - Hepatic function: check liver enzymes in patients with liver disease. - Blood glucose: monitor glucose levels in diabetics or hyperglycaemic risk. - Electrolytes: assess serum electrolytes prior to and during therapy. - Infusion rate: administer according to recommended speed to reduce irritation. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino acid solutions can interact with other intravenous therapies and metabolic modifiers.

Major Interactions (Avoid): - High‑dose insulin: may precipitate severe hypoglycaemia when combined with amino‑acid‑rich solutions. - Potassium‑rich fluids: risk of hyperkalemia if administered concurrently.

Moderate Interactions (Monitor Closely): - Loop diuretics: may exacerbate electrolyte shifts. - Corticosteroids: can increase protein catabolism, altering the intended benefit. - Parenteral nutrition admixtures: require compatibility testing to prevent precipitation. - Anticoagulants: monitor coagulation parameters as amino acids may affect platelet function.